Embolisation for pulmonary arteriovenous malformation

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 1, 2015, Pages

  Hsu, Charlie C T ^a   Kwan, Gigi N C ^a   Thompson, Shane A ^b   Evans Barns, Hannah ^c   van Driel, Mieke L ^d,e,f  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b South Coast Radiology   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e BOND UNIVERSITY   (Australia)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY SURGERY; BLOOD OXYGENATION; BRAIN ABSCESS; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COIL EMBOLIZATION; DISEASE REGISTRY; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; LUNG ARTERY; LUNG HEMORRHAGE; LUNG VEIN; MEDICAL ETHICS; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VEIN SURGERY; ABNORMALITIES; ADVERSE EFFECTS; ARTERIOVENOUS MALFORMATIONS; ARTIFICIAL EMBOLIZATION; PROCEDURES; PULMONARY ARTERY; PULMONARY VEIN;

ARTERIOVENOUS MALFORMATIONS; EMBOLIZATION, THERAPEUTIC; HUMANS; PULMONARY ARTERY; PULMONARY VEINS;

EID: 85011580459     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008017.pub4     Document Type: Review

References (49)

1. Dutton JA, Jackson JE, Hughes JM, Whyte MK, Peters AM, Ussov W, et al.Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. American Journal of Roentgenology 1995;165(5):1119-25.
2. Gupta P, Mordin C, Curtis J, Hughes JM, Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. American Journal of Roentgenology 2002;179(2):347-55.
3. Haitjema TJ, Overtoom TT, Westermann CJ, Lammers JW. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995;50(7):719-23.
4. Lacombe P, Lagrange C, Beauchet A, El Hajjam M, Chinet T, Pelage JP. Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long-term results of embolization according to the extent of lung involvement. Chest 2009;135(4):1031-7.
5. Liu FY, Wang MQ, Fan QS, Duan F, Wang ZJ, Song P. Endovascular embolization of pulmonary arteriovenous malformations. Chinese Medical Journal 2010;123(1):23-8.
6. Pollak JS, Egglin TK, Rosenblatt MM, Dickey KW, White RI Jr. Clinical results of transvenous systemic embolotherapy with a neuroradiologic detachable balloon. Radiology 1994;191(2):477-82.
7. Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI Jr. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. Journal of Vascular and Interventional Radiology 2006;17(1):35-45.
8. Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, et al.Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008;63(3):259-66.
9. Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. European Respiratory Journal 2008;32(1):162-9.
10. NCT01856842. Reperfusion of pulmonary arteriovenous malformations after embolotherapy. A randomized trial of Interlock™ Fibered IDC™ Occlusion System vs. Nester Coils. https://clinicaltrials.gov/ct2/show/NCT01856842 (accessed 03 December 2014).
11. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Journal of Medical Genetics 2006;43(2):97-110.
12. Bayrak-Toydemir P, Mao R, Lewin S, McDonald J. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genetics in Medicine 2004;6(4):175-91.
13. Borrero CG, Zajko AB. Pulmonary arteriovenous malformations: clinical Features, diagnosis, and treatment. Journal of Radiology Nursing 2006;25(2):33-7.
14. Brillet PY, Dumont P, Bouaziz N, Duhamel A, Laurent F, Remy J, et al.Pulmonary arteriovenous malformation treated with embolotherapy: systemic collateral supply at multidetector CT angiography after 2-20-year follow-up. Radiology 2007;242(1):267-76.
15. Cil B, Peynircioğlu B, Canyiğit M, Geyik S, Ciftçi T. Peripheral vascular applications of the Amplatzer vascular plug. Diagnostic and Interventional Radiology 2008;14(1):35-9.
16. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. American Journal of Respiratory Criticial Care Medicine 2004;169(9):994-1000.
17. Curie A, Lesca G, Cottin V, Edery P, Bellon G, Faughnan ME, et al.Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases. Journal of Pediatrics 2007;151(3):299-306.
18. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Human Mutation 2002;19(2):140-8.
19. Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, et al.Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000;117(1):31-8.
20. Faughnan ME, Thabet A, Mei-Zahav M, Colombo M, Maclusky I, Hyland RH, et al.Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolotherapy. Journal of Pediatrics 2004;145(6):826-31.
21. Ferro C, Rossi UG, Bovio G, Seitun S, Rossi GA. Percutaneous transcatheter embolization of a large pulmonary arteriovenous fistula with an Amplatzer vascular plug. Cardiovascular and Interventional Radiology 2007;30(2):328-31.
22. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk D. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004;363(9412):852-9.
23. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. European Journal of Human Genetics 2009;17(7):860-71.
24. Hannan EL, O'Donnell JF, Kilburn H Jr, Bernard HR, Yazici A. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA 1989;262(4):503-10.
25. Hayashi S1, Baba Y, Senokuchi T, Nakajo M. Efficacy of venous sac embolization for pulmonary arteriovenous malformations: comparison with feeding artery embolization. Journal of Vascular and Interventional Radiology 2012;23(12):1566-77.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Khurshid I, Downie GH. Pulmonary arteriovenous malformation. Postgraduate Medical Journal 2002;78(918):191-7.
28. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. Journal of Internal Medicine 1999;245(1):31-9.
29. Lee DW, White RI Jr, Egglin TK, Pollak JS, Fayad PB, Wirth JA, et al.Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Annals of Thoracic Surgery 1997;64(4):930-40.
30. Mager JJ, Overtoom TT, Blauw H, Lammers JW, Westermann CJ. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. Journal of Vascular and Interventional Radiology 2004;15(5):451-6.
31. Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, et al.Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clinical Neurology and Neurosurgery 2012;114(3):235-40.
32. Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI Jr. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience. Chest 2008;133(3):653-61.
33. Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, et al.Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66(2):202-5.
34. Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. Journal of Vascular and Interventional Radiology 2004;15(2 Pt 1):153-60.
35. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992;182(3):809-16.
36. Remy J, Remy-Jardin M, Giraud F, Wattinne L. Angioarchitectureof pulmonary arteriovenous malformations:clinical utility of 3D helical CT. Radiology 1994;191(3):657-64.
37. Remy-Jardin M, Dumont P, Brillet PY, Dupuis P, Duhamel A, Remy J. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. Radiology 2006;239(2):576-85.
38. Sabbà C, Pasculli G, Suppressa P, D'Ovidio F, Lenato GM, Resta F, et al.Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM: An International Journal of Medicine 2006;99(5):327-34.
39. Sagara K, Miyazono N, Inoue H, Ueno K, Nishida H, Nakajo M. Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. American Journal of Roentgenology 1998;170(3):727-30.
40. Saluja S, Sitko I, Lee DW, Pollak J, White RI Jr. Embolotherapy of pulmonary arteriovenous malformations with detachable balloons: long-term durability and efficacy. Journal of Vascular and Interventional Radiology 1999;10(7):883-9.
41. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al.Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). American Journal of Medical Genetics 2000;91(1):66-7.
42. Shovlin CL, Sodhi V, McCarthy A, Lasjaunias P, Jackson JE, Sheppard MN. Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services. BJOG: An International Journal of Obstetrics and Gynaecology 2008;115(8):1108-15.
43. Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations and other pulmonary vascular abnormalities. In: Mason, Broaddus, Martin, Schraufnagel, Murray, Nadel editor(s). Murray and Nadel's Textbook of Respiratory Medicine, 5th Edition. Pennsylvania: Elsevier-Saunders, 2010.
44. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clinic Proceedings 1999;74(7):671-80.
45. White RI Jr, Mitchell SE, Barth KH, Kaufman SL, Kadir S, Chang R, et al.Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. American Journal of Roentgenology 1983;140(4):681-6.
46. White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, et al.Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988;169(3):663-9.
47. White RI Jr. Pulmonary Arteriovenous Malformations: How Do I Embolize?. Techniques in Vascular and Interventional Radiology 2007;10(4):283-90.
48. Hsu CCT, Kwan GNC, Thompson SA, van Driel ML. Embolisation therapy for pulmonary arteriovenous malformations. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD008017.pub2]
49. Hsu CC, Kwan GN, Thompson SA, van Driel ML. Embolisation therapy for pulmonary arteriovenous malformations. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD008017.pub3]